Recombinant Mouse DBH-like monooxygenase protein 2 (Moxd2), partial

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference during order placement for customized preparation.
Lead Time
Delivery times vary depending on the purchase method and location. Please consult your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to settle the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50%, which can serve as a reference.
Shelf Life
Shelf life depends on storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type is determined during manufacturing.
The tag type is determined during production. If you require a specific tag, please inform us; we will prioritize its development.
Synonyms
Moxd2; Dbhl; Dbhl1; DBH-like monooxygenase protein 2; EC 1.14.17.-; Dopamine-beta-hydroxylase-like protein
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Protein Length
Partial
Purity
>85% (SDS-PAGE)
Species
Mus musculus (Mouse)
Target Names
Moxd2
Uniprot No.

Target Background

Database Links
Protein Families
Copper type II ascorbate-dependent monooxygenase family
Subcellular Location
Membrane; Single-pass type I membrane protein.
Tissue Specificity
Expressed at low levels in thymus and testis.

Q&A

What is Moxd2 and what are its basic structural characteristics?

Moxd2 (monooxygenase, DBH-like 2) is a protein-coding gene found in Mus musculus (house mouse) with the Entrez Gene ID 194357 and synonym Dbhl1 . The MOXD2 protein is a membrane-bound monooxygenase structurally similar to dopamine-β-hydroxylase and has been proposed to be associated with olfactory function . Analysis of the protein structure reveals highly conserved domains across mammalian species, with the chimpanzee and gray short-tailed opossum (Monodelphis domestica) MOXD2 proteins exhibiting 82.4% amino acid sequence identity . The protein contains two key structural features that determine its cellular localization and function: an endoplasmic reticulum (ER) signal peptide at the N-terminus that directs the protein into the secretory pathway, and typically a glycosylphosphatidylinositol (GPI) anchor signal at the C-terminus that anchors the protein to cell membranes .

What are the general approaches to expressing recombinant Moxd2 protein?

Expression of recombinant Moxd2 typically begins with acquiring a verified cDNA ORF clone, which can be obtained from specialized repositories that offer next-day shipping of validated constructs . For efficient expression, researchers should consider the following methodology: (1) Select an appropriate expression system based on experimental requirements (bacterial, yeast, insect, or mammalian); (2) Design constructs with optimization of codon usage for the host system; (3) Include appropriate tags (His, FLAG, or GST) for purification and detection; (4) Consider inclusion or exclusion of the ER signal peptide and GPI anchor signal depending on whether soluble or membrane-bound protein is desired; (5) Validate expression through Western blotting with antibodies against the protein or attached tags; and (6) Optimize purification protocols that account for the hydrophobic nature of the membrane-associated regions if the full-length protein is expressed.

How is Moxd2 gene expression regulated in mice?

Moxd2 gene expression regulation in mice involves tissue-specific control mechanisms primarily associated with olfactory tissues. Methodologically, researchers investigating Moxd2 expression should employ quantitative PCR (qPCR) with carefully designed primers spanning exon-exon junctions to avoid genomic DNA amplification. Northern blotting can provide information about transcript variants, while in situ hybridization offers spatial expression data. For protein-level analysis, immunohistochemistry using validated antibodies against Moxd2 is recommended. When analyzing expression data, it is important to normalize against appropriate housekeeping genes stable in the tissues of interest. Evolutionary analysis has revealed that Moxd2 expression patterns correlate with olfactory function across species, with functional expression in species relying heavily on olfaction and gene inactivation in species with reduced olfactory dependence .

How should researchers design experiments to investigate Moxd2 function in olfactory processes?

To effectively investigate Moxd2 function in olfactory processes, researchers should implement a comprehensive experimental design that follows these five key steps:

  • Define variables: Identify independent variables (e.g., Moxd2 expression levels, mutations) and dependent variables (e.g., olfactory behavioral responses, electrophysiological measurements) .

  • Formulate specific, testable hypotheses: For example, "Knockout of Moxd2 in mice will result in diminished ability to detect specific odorants compared to wild-type controls" .

  • Design experimental treatments: Create treatment groups including knockouts, knockdowns, overexpression models, and controls with careful consideration of genetic background effects .

  • Assign subjects appropriately: Utilize either between-subjects design (comparing different groups of mice) or within-subjects design (measuring the same mice before and after intervention) .

  • Plan measurements: Establish precise protocols for measuring olfactory function through behavioral assays (e.g., buried food tests, odor preference tests) and physiological measurements (e.g., electro-olfactogram recordings) .

What statistical approaches are recommended for analyzing evolutionary patterns of Moxd2 across species?

Analysis of evolutionary patterns of Moxd2 requires robust statistical methods similar to those employed in previous studies of this gene. The recommended methodological approach includes:

  • Calculate the ratio of nonsynonymous to synonymous substitution rates (dN/dS, ω) using likelihood methods implemented in software packages such as PAML .

  • Prepare separate datasets for different taxonomic groups (e.g., catarrhine primates, whales) to analyze lineage-specific selection patterns .

  • Compare different evolutionary models using likelihood ratio tests to determine which best fits the data:

    • One-ratio model (uniform ω across all branches)

    • Two-ratio models (allowing different ω values for specific lineages)

    • Free-ratio model (branch-specific ω values)

  • Calculate statistical significance using twice the log likelihood difference [2Δ(ln L)] and appropriate degrees of freedom, with P-values determined using the chi-square distribution .

For example, in previous analyses of catarrhine primates, researchers found that a two-ratio model allowing different ω values for human and orangutan branches (ω1 = 0.74234) versus other branches (ω0 = 0.15926) fit significantly better than a one-ratio model (P = 7.57×10⁻⁶), indicating relaxed selection pressure in these species .

How can researchers effectively analyze Moxd2 protein localization and trafficking?

To effectively analyze Moxd2 protein localization and trafficking, researchers should implement a multi-faceted approach combining molecular biology, imaging techniques, and biochemical methods:

  • Construct fusion proteins: Generate Moxd2-fluorescent protein fusions (GFP, mCherry) with careful consideration of tag placement to avoid disrupting the N-terminal ER signal peptide or C-terminal GPI anchor signal .

  • Perform subcellular fractionation: Separate membrane-bound and soluble fractions through differential centrifugation, followed by Western blot analysis to determine the proportion of Moxd2 in each fraction.

  • Employ immunofluorescence microscopy: Use validated antibodies against Moxd2 or epitope tags combined with markers for cellular compartments (ER, Golgi, plasma membrane) to visualize localization.

  • Conduct live-cell imaging: Monitor trafficking dynamics in real-time using confocal microscopy with photobleaching techniques (FRAP, FLIP) to assess mobility and turnover rates.

  • Analyze post-translational modifications: Investigate glycosylation patterns through glycosidase treatments and mass spectrometry to understand processing through the secretory pathway.

This methodological framework allows researchers to characterize the impact of mutations on Moxd2 trafficking, particularly those affecting the C-terminal GPI anchor signal, such as the 13-nt deletion observed in Old World cercopithecine monkeys that converts the membrane-bound protein to a soluble form .

What is the significance of Moxd2 gene loss in certain mammalian lineages?

The significance of Moxd2 gene loss in certain mammalian lineages appears to be closely linked to the evolution of olfactory function. Research methodologies for investigating this relationship should include:

  • Comprehensive comparative genomic analysis across diverse mammalian species to identify patterns of gene conservation, pseudogenization, or complete loss.

  • Correlation analysis between Moxd2 genetic status and ecological factors, particularly sensory reliance patterns in different species.

  • Functional assays comparing olfactory capabilities between species with intact versus non-functional Moxd2.

Analysis of 64 mammalian species has revealed loss-of-function mutations in Moxd2 genes across several lineages, including apes (humans, Sumatran and Bornean orangutans, and five gibbon species), toothed whales (killer whales, bottlenose dolphins, finless porpoises, baijis, and sperm whales), and baleen whales (minke whales and fin whales) . This pattern of gene loss strongly correlates with lineages that have evolved reduced reliance on olfaction, particularly in aquatic environments (whales) and in primates with enhanced visual systems (apes) . The consistent independent loss of Moxd2 function across these distantly related lineages suggests a common selective pressure related to sensory evolution, potentially indicating that Moxd2 function becomes dispensable when other sensory modalities become dominant.

How does the 13-nt deletion in Old World cercopithecine monkeys affect Moxd2 protein function?

The 13-nt deletion identified in the last exon of Moxd2 in Old World cercopithecine monkeys (including rhesus macaques, crab-eating macaques, olive baboons, and green monkeys) results in a C-terminal truncation that fundamentally alters the protein's cellular localization and likely its function . To investigate this alteration methodologically:

The deletion causes loss of the GPI-anchor signal, converting what would normally be a membrane-bound protein into a soluble form . This transformation would likely change the protein's substrate accessibility, interaction partners, and possibly its enzymatic efficiency. From an evolutionary perspective, this represents an intermediate state between fully functional membrane-bound Moxd2 and complete gene loss as seen in apes, potentially reflecting a gradual reduction in selection pressure on olfactory function in Old World monkeys compared to New World monkeys.

What molecular evolutionary patterns suggest relaxed selection on Moxd2 in certain lineages?

Molecular evolutionary analysis of Moxd2 across mammalian lineages reveals distinct patterns suggesting relaxed selection pressure in specific clades, particularly catarrhines and whales. The methodological approach for detecting these patterns includes:

  • Sequence alignment of Moxd2 coding regions from diverse species, with careful curation to remove disrupted regions resulting from mutations.

  • Application of statistical models to calculate dN/dS ratios (ω) across different lineages and test alternative evolutionary hypotheses.

  • Branch-specific analysis to identify when selection pressure changed during evolutionary history.

The analysis of catarrhine primates revealed:

  • Background branches showed ω₀ = 0.15926, indicating purifying selection

  • Human and orangutan branches showed ω₁ = 0.74234, indicating relaxed selection

  • Statistical testing confirmed significant difference between models (P = 7.57×10⁻⁶)

Similarly, in whales:

  • Background branches showed ω₀ = 0.15926

  • Whale branches showed ω₁ = 0.74234, also indicating relaxed selection

  • Statistical significance was strongly supported (P = 3.22×10⁻¹⁶)

These patterns suggest that selective pressure on Moxd2 function decreased in these lineages before complete gene inactivation occurred, consistent with a scenario where olfactory function became less critical for survival and reproduction in these species.

What are common challenges in expressing and purifying functional recombinant Moxd2?

Expressing and purifying functional recombinant Moxd2 presents several technical challenges that researchers should anticipate and address methodically:

  • Membrane protein solubility: As Moxd2 contains a GPI anchor signal, expression of the full-length protein often results in poor solubility and aggregation. Researchers should consider:

    • Using specialized detergents (CHAPS, DDM, or Triton X-100) for extraction

    • Creating truncated constructs that remove the GPI anchor signal

    • Employing fusion partners (MBP, SUMO) to enhance solubility

  • Post-translational modifications: Proper folding and function of Moxd2 likely depends on glycosylation patterns. Researchers should:

    • Select expression systems capable of mammalian-like glycosylation (insect or mammalian cells)

    • Analyze glycosylation profiles using mass spectrometry

    • Assess the impact of glycosylation on enzymatic activity

  • Activity preservation: Maintaining enzymatic function through purification requires:

    • Inclusion of stabilizing cofactors (copper ions for monooxygenase activity)

    • Optimization of buffer conditions (pH, ionic strength)

    • Rapid processing to minimize degradation

    • Activity assays at multiple purification stages to track specific activity

  • Expression yield: Obtaining sufficient quantities of protein often requires:

    • Codon optimization for the expression host

    • Inducible promoter systems with optimized induction parameters

    • Scale-up strategies including bioreactor culture for mammalian or insect cells

For researchers interested in comparative studies, it is worth noting that the 13-nt deletion in Old World cercopithecine monkeys produces a naturally soluble form of the protein that may be easier to express and purify for functional studies .

How can researchers validate antibodies for Moxd2 detection in experimental systems?

Proper validation of antibodies for Moxd2 detection is critical for obtaining reliable experimental results. A comprehensive antibody validation methodology should include:

  • Specificity assessment:

    • Western blot analysis using positive controls (tissues known to express Moxd2) and negative controls (tissues from Moxd2 knockout animals or species with natural gene loss, such as humans)

    • Immunoprecipitation followed by mass spectrometry to confirm target identity

    • Peptide competition assays to verify epitope specificity

  • Cross-reactivity evaluation:

    • Testing against recombinant Moxd2 proteins from different species

    • Comparative analysis with related proteins (especially MOXD1) to ensure antibody does not cross-react

    • Assessment in tissues from species with documented Moxd2 loss-of-function mutations

  • Application-specific validation:

    • For Western blotting: Determination of optimal concentrations, blocking conditions, and detection methods

    • For immunohistochemistry: Optimization of fixation protocols, antigen retrieval methods, and visualization systems

    • For immunofluorescence: Confirmation of subcellular localization patterns matching predicted distribution (membrane-bound versus soluble forms)

  • Reproducibility verification:

    • Testing multiple antibody lots

    • Comparing results using antibodies targeting different epitopes

    • Documentation of all validation steps in accordance with best practices

This rigorous validation approach is particularly important given the evolutionary variability of Moxd2 across species and the existence of different protein forms (membrane-bound versus soluble) that might affect epitope accessibility.

What are recommended approaches for analyzing contradictory data in Moxd2 functional studies?

When encountering contradictory data in Moxd2 functional studies, researchers should implement a systematic analytical framework to resolve discrepancies:

  • Methodological reconciliation:

    • Compare experimental designs across studies, identifying differences in model systems, genetic backgrounds, and technical approaches

    • Evaluate reagent quality and specificity, particularly antibodies and recombinant proteins

    • Assess statistical power and analytical methods used in conflicting studies

  • Biological context consideration:

    • Analyze species-specific differences, as Moxd2 shows significant evolutionary variation

    • Consider developmental timing, as gene function may vary across life stages

    • Evaluate tissue-specific effects, particularly in olfactory versus non-olfactory tissues

  • Hypothesis refinement:

    • Develop testable predictions that could explain contradictions

    • Design experiments specifically targeted at resolving discrepancies

    • Consider alternative models of Moxd2 function that accommodate seemingly contradictory results

  • Integration of multiple approaches:

    • Combine in vitro biochemical assays with in vivo functional studies

    • Supplement genetic approaches (knockout, knockdown) with pharmacological interventions

    • Incorporate evolutionary analysis to contextualize functional differences

When presenting contradictory data, researchers should transparently report all findings, contextualize results within the broader literature, and propose rigorous experiments to resolve discrepancies rather than selectively highlighting data that supports a preferred hypothesis.

How can evolutionary changes in Moxd2 inform our understanding of sensory system evolution?

Evolutionary changes in Moxd2 provide a valuable model for understanding sensory system evolution through a methodological approach that integrates comparative genomics, molecular evolution, and functional analysis:

  • Conduct comprehensive phylogenetic analysis:

    • Map Moxd2 genetic status (functional, pseudogenized, deleted) across mammalian phylogeny

    • Identify independent instances of gene loss or alteration

    • Estimate timing of genetic changes through molecular clock approaches

  • Correlate genetic changes with sensory ecology:

    • Compare Moxd2 status with ecological niche parameters

    • Analyze relationship between Moxd2 function and anatomical features of olfactory systems

    • Assess potential trade-offs between olfaction and other sensory modalities

  • Evaluate patterns of convergent evolution:

    • Analyze the remarkable convergent loss of Moxd2 function in apes and whales

    • Test for molecular convergence in other olfactory genes in these lineages

    • Investigate whether similar patterns occur in other semi-aquatic mammals or visually-oriented species

The observed pattern of Moxd2 loss in apes and whales strongly supports the hypothesis that this gene plays a specific role in olfactory function that becomes dispensable when species evolve enhanced reliance on other sensory modalities . This represents a clear example of how relaxed selection can lead to convergent gene loss in distantly related lineages experiencing similar selective pressures, providing insight into the molecular basis of sensory trade-offs during evolution.

What methods should be used to investigate potential non-olfactory functions of Moxd2?

While evidence suggests a primary role in olfaction, investigating potential non-olfactory functions of Moxd2 requires an unbiased, comprehensive methodological approach:

  • Transcriptomic analysis:

    • Perform RNA-Seq across diverse tissue types to identify non-olfactory expression sites

    • Analyze single-cell transcriptomics in identified tissues to determine specific cell types expressing Moxd2

    • Compare expression patterns across species with intact versus non-functional Moxd2

  • Protein interaction studies:

    • Conduct yeast two-hybrid or proximity labeling (BioID, APEX) experiments to identify interaction partners

    • Perform co-immunoprecipitation followed by mass spectrometry

    • Validate key interactions through FRET or BiFC approaches

  • Phenotypic analysis of model systems:

    • Generate tissue-specific conditional knockout models to bypass potential developmental effects

    • Implement comprehensive phenotyping beyond olfactory tests (metabolic, neurological, behavioral)

    • Utilize CRISPR-Cas9 to introduce specific mutations mimicking those found in natural populations

  • Biochemical function investigation:

    • Characterize enzymatic activity using diverse substrate panels

    • Analyze potential roles in neurotransmitter metabolism (given similarity to dopamine-β-hydroxylase)

    • Investigate tissue-specific enzymatic activities and substrate preferences

This systematic approach would help determine whether Moxd2 has pleiotropic functions beyond olfaction, potentially explaining aspects of its evolutionary history that are not fully accounted for by changes in olfactory reliance alone.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.